Substance use disorders among inhalant users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, 2218 Elder Street, 2B, DUMC Box 3419, Durham, NC 27710, USA. <>
Addictive Behaviors (Impact Factor: 2.76). 08/2008; 33(7):968-73. DOI: 10.1016/j.addbeh.2008.02.019
Source: PubMed


To assess the prevalence, correlates, and age of onset of DSM-IV substance use disorders (SUDs) among adult inhalant users.
Analyses were based on structured psychiatric interviews of a nationally representative sample of 43,093 US adults.
The lifetime prevalence of SUDs among adult inhalant users was 96%. Alcohol (87%), marijuana (68%), nicotine (58%), cocaine (35%), hallucinogen (31%), and stimulant (28%) use disorders were more prevalent than inhalant use disorders (19%). An estimated 62% of inhalant users met criteria for a past-year SUD. Less education, residence in non-metropolitan areas, early onset of inhalant use, and a history of substance abuse treatment were associated with increased odds of having an inhalant use disorder. Inhalant users who were under age 30 or who were members of families with low incomes had increased odds of having nicotine dependence and an alcohol or drug use disorder in the past year. Compared with substance users without a history of inhalant use, inhalant users, on average, initiated use of cigarettes, alcohol, and almost all other drugs at younger ages, and had a higher lifetime prevalence of nicotine, alcohol, and any drug use disorder.
Lifetime and past-year SUDs are prevalent among adults with a history of inhalant use.

Download full-text


Available from: Li-Tzy Wu,
9 Reads
  • Source
    • "the findings of this study mirror previous research, which indicates that individuals who use volatile substances are more likely to report axis i mood disorders and poly-substance use (Wu, Howard, & pilowsky, 2008; Wu & Howard, 2007; Wu & ringwalt, 2006). in addition to highlighting the current links between vsu and physical and psychiatric health conditions, this study provides an added layer of evidence that past traumatic life experiences influence current experiences of health and well-being. this is the first study of its kind to report on traumatic events associated with vsu in an adult population, though previous studies have explored associations between trauma and solvent use in adolescent populations (Howard, balster, cottler, Wu, & vaughn, 2008; perron, Howard, Maitra, & vaughn, 2009; perron & Howard, 2009). the presence of traumatic lifetime events in this study was not meant to represent the prevalence of posttraumatic stress disorder in this population, but rather to elucidate one of the ways in which the cumulative and intergenerational trauma extends to the everyday experiences of aboriginal peoples. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study explored the prevalence of volatile substance use (VSU) in a community of homeless adults. The importance of individual life history characteristics (history of traumatic events, residential school history, mental and physical health conditions) were also examined with respect to past-year volatile substance use in this sample. Overall, the results indicate that a variety of traumatic events, particularly residential school history and a number of mental and physical health conditions, were significantly associated with VSU in this urban Canadian sample. These findings have novel implications for community interventions for VSU and highlight the importance of conceptualizing cultural and historical traumas in understanding VSU.
    Canadian journal of community mental health = Revue canadienne de santé mentale communautaire 06/2015; 34(2):1-15. DOI:10.7870/cjcmh-2015-003
  • Source
    • "Solvent use is associated with individuals from the most socio-economically disadvantaged populations, alongside a disproportionately higher burden of psychiatric and physical morbidities[50]–[57]. The findings from this study align with literature demonstrating a higher burden of infectious diseases among solvent users[42], [58]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We previously identified a high prevalence of Hepatitis C (HCV) amongst solvent-using injection drug users (S-IDU) relative to other injection drug users within the same locality. Here we incorporated social network variables to better characterize some of the behavioural characteristics that may be putting this specific subgroup of IDU at elevated disease risk. A cross-sectional survey of at-risk populations was carried out in Winnipeg, Canada in 2009. Individuals reporting any history of injection drug and/or solvent use were included in the study. Associations between subgroup membership, infection with HCV and HIV and individual and social network variables were examined. In relation to other IDU, S-IDU were more likely to be infected with HCV, to report ever having shared a syringe, and to associate with other IDU. They were further differentiated in terms of their self-reported sexual orientation, ethnicity and in the injection drugs typically used. Solvent use stands as a proxy measure of numerous other characteristics that put this group of IDU at higher risk of infection. Provision of adequate services to ostracized subpopulations may result in wider population-level benefits.
    PLoS ONE 02/2014; 9(2):e88623. DOI:10.1371/journal.pone.0088623 · 3.23 Impact Factor
  • Source
    • "In addition to psychiatric disorders, personal history of substance abuse treatment and familial history of substance abuse were examined as correlates for opioid use. A personal history of substance abuse treatment was defined as having ever received any treatment services for problems related to alcohol or drug use at any location (an inpatient ward, outpatient clinic, emergency room, addiction treatment program, mental health treatment program, jail, or self-help groups) (Grant et al., 2004; Wu, Howard, and Pilowsky, 2008). Familial substance abuse included any self-reported, positive family history of alcohol or drug use problems among any of the respondent's biological family members (natural parents, sons, daughters, grandparents, full brothers, and full sisters) (Wu et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: To study substance use and psychiatric disorders among prescription opioid users, heroin users, and non-opioid drug users in a national sample of adults. Analyses of data from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (N=43,093). Four groups were identified among 9140 illicit or non-prescribed drug users: heroin-other opioid users (1.0%; used heroin and other opioids), other opioid-only users (19.8%; used other opioids but never heroin), heroin-only users (0.5%; used heroin but never other opioids), and non-opioid drug users (78.7%; used drugs but never heroin or other opioids). After adjusting for variations in socioeconomic characteristics, history of substance abuse treatment, and familial substance abuse, heroin-other opioid users had greater odds of several substance use disorders (cocaine, hallucinogen, sedative, amphetamine, and tranquilizer) as compared with the other groups; heroin-only users had reduced odds of sedative and tranquilizer use disorders as compared with other opioid-only users. Non-opioid drug users had reduced odds of all substance use disorders and other mental disorders (mood, anxiety, pathological gambling, and personality) as compared with other opioid-only users. Past-year other opioid-only users also reported slightly lower scores on quality of life than past-year non-opioid drug users. All opioid use groups had higher rates of substance use disorders than non-opioid drug users, and these rates were particularly elevated among heroin-other opioid users. Findings suggest the need to distinguish between these four groups in research and treatment as they may have different natural histories and treatment needs.
    Journal of Addiction Medicine 03/2011; 5(1):28-35. DOI:10.1097/ADM.0b013e3181e0364e · 1.76 Impact Factor
Show more